Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.
about
Understanding and overcoming metformin gastrointestinal intolerance.Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.ANTIOXIDANT ACTIVITY AND A-AMYLASE INHIBITORY POTENTIAL OF ROSA CANINA L.Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism.A novel botanical formula prevents diabetes by improving insulin resistance.Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors.Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.Reappraisal and perspectives of clinical drug-drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus.Diabetes-induced mechanophysiological changes in the small intestine and colon.Monotherapy in Patients with Type 2 Diabetes Mellitus.Monotherapy in patients with type 2 diabetes mellitus.Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives.α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study.Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors.The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus.Synthesis, α-glucosidase inhibition and molecular docking studies of novel thiazolidine-2,4-dione or rhodanine derivativesEfficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Tr
P2860
Q30240030-BA95DDE2-3F5F-4987-AED9-9E454B3BCEABQ30249371-7C0C0809-0141-4B38-AC3C-1B14B19C468EQ33732834-F27D8945-C562-4ADE-B07E-A066B2FFCFCAQ33767379-76768ABB-1C75-40E4-BE1E-3DA417496C88Q33876987-60A2595B-FFC8-41F3-836B-43DFB84922D2Q38634585-F16AD89F-EB0F-452F-9F8F-442D04F03814Q38783130-491742BD-CEAF-48EA-9A5D-A2B2F798996BQ39051791-5C763879-9A15-4D62-9585-9725D3A91BABQ39427195-D419D8A7-47A8-4ED6-B8BF-8CCF624B4D76Q47110030-9CD08459-E56F-4369-B3C4-782C0935BD6AQ47123503-9124A10E-CF52-435E-B884-FEC00975287DQ47398531-F1E1BBFD-4B26-4096-A473-96A73B14CDD2Q47671042-464E43E8-7833-48B2-8761-2745355325E4Q48316576-F158BE60-AF0E-482C-95F1-B93580F03950Q50909368-01D5E7A4-ECAE-471C-AB1A-3FE3ACED47C2Q55114052-4141D994-3876-4D74-9335-F59EBC61866FQ57093715-927F46F3-C07D-4D51-B271-2433ED923B14Q58581291-C749B1AA-3174-4923-BFE3-566FC7306C5A
P2860
Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic potential of α-glu ...... tus: an evidence-based review.
@en
type
label
Therapeutic potential of α-glu ...... tus: an evidence-based review.
@en
prefLabel
Therapeutic potential of α-glu ...... tus: an evidence-based review.
@en
P2093
P2860
P1476
Therapeutic potential of α-glu ...... tus: an evidence-based review.
@en
P2093
Eberhard Standl
Nanwei Tong
Parag Shah
Rahul Rathod
Shashank R Joshi
P2860
P304
P356
10.1517/14656566.2015.1070827
P407
P50
P577
2015-09-01T00:00:00Z